| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.03B | +0.9% |
| Cost of Revenue | $1.32B | +10.3% |
| Gross Profit | $2.71B | -3.1% |
| R&D Expense | $369.9M | +1.6% |
| SG&A Expense | $1.76B | -0.4% |
| Operating Income | $545.8M | -10.2% |
| Pre-tax Income | $585.3M | -3.9% |
| Income Tax | $174.9M | -6.7% |
| Net Income | $410.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.09B | +4.9% |
| Accounts Receivable | $1.10B | +10.7% |
| Inventory | $226.3M | -11.0% |
| Current Assets | $2.62B | +5.0% |
| Total Assets | $6.23B | +0.3% |
| Current Liabilities | $1.92B | -5.8% |
| Total Liabilities | $2.18B | -7.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $593.2M | -19.6% |
| Capital Expenditures | $102.4M | -11.4% |
| Investing Cash Flow | -$112.4M | +55.9% |
| Financing Cash Flow | -$464.6M | -30.6% |
| Free Cash Flow | $490.8M | -21.2% |
| -2.6% |
| EPS (Basic) | $5.66 | +0.5% |
| EPS (Diluted) | $5.65 | +0.5% |
| Stockholders' Equity |
| $4.05B |
| +5.1% |